Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.
Share:
More In Business
One Woman’s Journey ‘From the Battlefield to the Boardroom’
Dr. Sonja Stribling discusses her new book, how she built her career as a nine-figure entrepreneur, and why mentorship is crucial.
The Fed Should Be ‘Patient’ When Lowering Rates
Glen Smith, CIO at GDS Wealth Management, shares how investors can allocate their assets as the market broadens and why he’s eyeing June for the first potential rate cut.
Is 2024 the Most Affordable Year to Buy a New Car?
After years of price increases for cars and trucks in the United States, costs are slowing and in some cases falling, helping cool overall inflation and giving frustrated Americans more hope of finding an affordable vehicle.
Missed Out on Nvidia? Consider These 5 Chip Stocks Instead
Missed out on the Nvidia wave? Oh course you did — you’re reading this article aren’t you, instead of luxuriating on a white-sand beaches of Bali. But here are at least four other promising semiconductor stocks to add to your portfolio.
The Hidden Costs of ‘Buy Now, Pay Later’
MarketWatch reporter Venessa Wong explains what consumers might be missing when they use popular ‘buy now, pay later’ services.
Why Small Business Owners Are Cautious This Year
Robert Rodriguez, Managing Director, Northeast Divisional Director at Chase for Business breaks down the bank’s latest small business report.
Building Lapse, a New Social Media App
Fresh off a successful funding round, co-founder of Lapse Dan Silvertown shares thoughts on regulation, privacy, and why the money for great startups is still out there.
2024 Is Just the ‘Beginning’ of Tech’s A.I. Rally
Sylvia Jablonski, CEO and CIO at Defiance ETFs, discusses why she’s bullish about this year’s market – unless the Fed changes its mind on rate cuts.
Surge Pricing: The Bane of Uber-Riders, Ticket-Buyers and...Wendy's Customers
Wendy's announced they are testing out fluctuating prices throughout the day for certain products based on demand. Who will groan the most: lunch-breakers, dinner drivers or late-night goblins?
